Sanders asks why once-free drug now costs $375,000 a year

The Hill: Sen. Bernie Sanders (I-Vt.) on Monday asked a pharmaceutical company why a drug that was once free for patients now costs as much as $375,000 annually.

Catalyst Pharmaceuticals informed investors in December about the new pricing for Firdapse, which is used to treated the rare neuromuscular disorder Lambert-Eaton Myasthenic Syndrome (LEMS), Sanders wrote in a letter to the company.

Read article